> Welcome to community Information > Cancer Care Technologies > Technology in Surgery and Therapy > Index: All Articles
When prostate cancer spreads throughout the body, and particularly to the bones, it is far more difficult to treat. Australian clinicians and researchers, with the assistance and fundraising efforts of ANZUP, the Prostate Cancer Foundation of Australia and Movember, are at the forefront of using a precision pharmaceutical labelled with radioactive isotope to treat these cases.
The project involves the collaborative work of Peter MacCallum Cancer Institute, partnering hospitals in all of the mainland states, ANSTO, and the pharmaceutical company Endocyte, to design a treatment that can be delivered nationally to all patients recruited to the trial.
From very encouraging results obtained in the early Australian trials, the research group have announced the launch of a worldwide clinical trial for the treatment of prostate cancer patients with widespread bony metastases.
Click on this video to learn more about the therapeutic procedure.
Theranostics
————————————————————————————–
> Welcome to community Information > Cancer Care Technologies > Technology in Surgery and Therapy > Index: All Articles
